Transcatheter mitral valve replacement (TMVR) Market: 2016 Product Intelligence


Posted November 15, 2017 by kishor8796

Infinium Global Research has added a new report on Global Transcatheter mitral valve replacement (TMVR) Market. The report predicts the market size of Transcatheter mitral valve replacement (TMVR) is expected to reach XX billion by 2022.

 
Infinium Global Research has added a new report on Global Transcatheter mitral valve replacement (TMVR) Market. The report predicts the market size of Transcatheter mitral valve replacement (TMVR) is expected to reach XX billion by 2022.
The mitral valve, also known as the bicuspid valve or left atrio-ventricular valve, is a dual-flap valve in the heart that lies between the left atrium and the left ventricle. The mitral valve and the tricuspid valve are known collectively as the atrio-ventricular valves because they lie between the atria and the ventricles of the heart. The mitral valve manages blood flow between left atrium and left ventricle; and prevents backward flow of the blood into left atrium. Mitral regurgitation is leakage of blood backward through the mitral valve each time the left ventricle contracts. This is a most common mitral valve disorder that causes abnormal blood flow. As a remedy for this problem, surgeons use mitral surgical vale repair procedures or transcatheter replacement methods.
Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/138

Some of the key driving factors attributing to the growth of this market include increasing number of patients with mitral valve disorders. Approximately 7 million people in the U.S., suffer from mitral regurgitation in the U.S., and they represent almost 2% of the nation's population. Similarly, approximately the same number of people suffer from the condition in Europe. This group includes 4.1 million people who have moderate to severe mitral regurgitation. The number of new patients suffering with mitral regurgitation disease added each year is 250,000. Among this 4.1 million patients, only about 20% or 1.67 million are eligible for the treatment. This creates huge opportunity for the global transcatheter mitral valve replacement market.
Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/138

Companies profiled:
Edwards Lifesciences Corp.
Abbott Laboratories
Medtronic
Micro Interventional Devices
Sinomed

Key topics covered:
1. Scope of the report
2. Executive summary
3. Qualitative analysis
4. Global TMVR market, by geography, 2015 - 2022
5. Company profiles

Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/transcatheter_mitral_valve_replacement_tmvr_market
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Infinium Global Research
Country India
Categories Health
Tags global transcatheter mitral valve replacement tmvr market , global transcatheter mitral valve replacement tmvr market report , global transcatheter mitral valve replacement tmvr market segments , transcatheter mitral valve replacement tmvr market demand , transcatheter mitral valve replacement tmvr market research , transcatheter mitral valve replacement tmvr market share analysis
Last Updated November 15, 2017